Steven G. Nadler

Person

Boothwyn, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 12,012,452
- Issue date Jun 18, 2024
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating systemic lupus erythematosus using a domain ant...
- Patent number 11,912,769
- Issue date Feb 27, 2024
- Bristol-Myers Squibb Company
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating systemic lupus erythematosus using a domain ant...
- Patent number 11,267,888
- Issue date Mar 8, 2022
- Bristol-Myers Squibb Company
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 11,180,567
- Issue date Nov 23, 2021
- Bristol-Myers Squibb Company
- Steven G. Nadler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 10,919,965
- Issue date Feb 16, 2021
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating immune diseases by administering antibody polyp...
- Patent number 10,196,451
- Issue date Feb 5, 2019
- Bristol-Myers Squibb Company
- Steven G. Nadler
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 9,908,937
- Issue date Mar 6, 2018
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 9,765,150
- Issue date Sep 19, 2017
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 9,228,018
- Issue date Jan 5, 2016
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 9,085,629
- Issue date Jul 21, 2015
- Bristol-Myers Squibb Company
- Murray McKinnon
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nucleic acids encoding antibody polypeptides that antagonize CD40L
- Patent number 8,981,072
- Issue date Mar 17, 2015
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody polypeptides that antagonize CD40L
- Patent number 8,895,010
- Issue date Nov 25, 2014
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 8,454,959
- Issue date Jun 4, 2013
- Bristol-Meyers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions monovalent for CD28 binding and methods of use
- Patent number 8,168,759
- Issue date May 1, 2012
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Polynucleotides and polypeptides associated with the development of...
- Patent number 7,670,785
- Issue date Mar 2, 2010
- Bristol-Myers Squibb Company
- Julie Carman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods involving glucocorticoid receptor site II
- Patent number 7,442,554
- Issue date Oct 28, 2008
- Bristol-Myers Squibb Company
- Arthur M. P. Doweyko
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Polynucleotides and polypeptides associated with the development of...
- Patent number 7,244,573
- Issue date Jul 17, 2007
- Bristol-Myers Squibb Company
- Julie Carman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of treating inflammatory and immune diseases using inhibito...
- Patent number 6,869,956
- Issue date Mar 22, 2005
- Bristol-Myers Squibb Company
- James R. Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Intracellular targeted delivery of compounds by 70 kD heat shock pr...
- Patent number 6,730,302
- Issue date May 4, 2004
- Bristol-Myers Squibb Company
- Sheri M. Fujihara
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions comprising a peptide inhibitor of nuclear protein tran...
- Patent number 5,962,415
- Issue date Oct 5, 1999
- Bristol-Myers Squibb Co.
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide inhibitors of nuclear protein translocation having nuclear...
- Patent number 5,877,282
- Issue date Mar 2, 1999
- Bristol-Myers Squibb Company
- Steven G. Nadler
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF DIAGNOSING AND TREATING LUPUS
- Publication number 20230236188
- Publication date Jul 27, 2023
- BRISTOL-MYERS SQUIBB COMPANY
- Laurence Celine Menard
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...
- Publication number 20220144951
- Publication date May 12, 2022
- Bristol-Myers Squibb Company
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20220073636
- Publication date Mar 10, 2022
- Bristol-Myers Squibb Company
- Steven G. NADLER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20210047414
- Publication date Feb 18, 2021
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...
- Publication number 20200247890
- Publication date Aug 6, 2020
- Bristol-Myers Squibb Company
- Xavier Valencia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING TRANSPLANT REJECTION USING A DOMAIN ANTIBODY DI...
- Publication number 20200231676
- Publication date Jul 23, 2020
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20190100595
- Publication date Apr 4, 2019
- Bristol-Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF DIAGNOSING AND TREATING LUPUS
- Publication number 20190086405
- Publication date Mar 21, 2019
- Bristol-Myers Squibb Company
- Laurence Celine Menard
- G01 - MEASURING TESTING
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20180142023
- Publication date May 24, 2018
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20180051091
- Publication date Feb 22, 2018
- Bristol-Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...
- Publication number 20170240636
- Publication date Aug 24, 2017
- Xavier Valencia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING TRANSPLANT REJECTION USING A DOMAIN ANTIBODY DI...
- Publication number 20170051059
- Publication date Feb 23, 2017
- Bristol-Myers Squibb Company
- Anish SURI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20160075790
- Publication date Mar 17, 2016
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20150299321
- Publication date Oct 22, 2015
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20150023976
- Publication date Jan 22, 2015
- Bristol -Myers Squibb Company
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20140099707
- Publication date Apr 10, 2014
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20130109846
- Publication date May 2, 2013
- Domantis Ltd.
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L
- Publication number 20130095109
- Publication date Apr 18, 2013
- Domantis Limited
- Steven G. NADLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20120201814
- Publication date Aug 9, 2012
- Domantis Ltd.
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE DEVELOPMENT OF...
- Publication number 20100119509
- Publication date May 13, 2010
- Bristol -Myers Squibb Company
- Julie Carman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE
- Publication number 20100028354
- Publication date Feb 4, 2010
- Bristol-Myers Squibb Company
- Murray McKinnon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polynucleotides and polypeptides associated with the development of...
- Publication number 20090004184
- Publication date Jan 1, 2009
- Bristol -Myers Squibb Company
- Julie Carman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Compositions and methods involving nuclear hormone receptor site II
- Publication number 20060223110
- Publication date Oct 5, 2006
- Arthur M.P. Doweyko
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Polynucleotides and polypeptides associated with the NF-kappaB pathway
- Publication number 20040171823
- Publication date Sep 2, 2004
- Steven G. Nadler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Polynucleotides and polypeptides associated with the NF-kB pathway
- Publication number 20040086896
- Publication date May 6, 2004
- Julie Carman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polynucleotides and polypeptides associated with the NF-kB pathway
- Publication number 20030224486
- Publication date Dec 4, 2003
- Julie Carman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polynucleotide encoding an activated human T-lymphocyte-derived pro...
- Publication number 20030190613
- Publication date Oct 9, 2003
- Michael A. Bowen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Polynucleotides and polypeptides associated with the development of...
- Publication number 20030170743
- Publication date Sep 11, 2003
- Julie Carman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Polynucleotides and polypeptides associated with the development of...
- Publication number 20030170742
- Publication date Sep 11, 2003
- Julie Carman
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Methods of treating inflammatory and immune diseases using inhibito...
- Publication number 20030022898
- Publication date Jan 30, 2003
- James R. Burke
- C07 - ORGANIC CHEMISTRY

Steven G. Nadler

Person

Patents Grantslast 30 patents

Compositions monovalent for CD28 binding and methods of use

Methods of treating systemic lupus erythematosus using a domain ant...

Methods of treating systemic lupus erythematosus using a domain ant...

Antibody polypeptides that antagonize CD40L

Compositions monovalent for CD28 binding and methods of use

Methods of treating immune diseases by administering antibody polyp...

Compositions monovalent for CD28 binding and methods of use

Antibody polypeptides that antagonize CD40L

Antibody polypeptides that antagonize CD40L

Compositions monovalent for CD28 binding and methods of use

Nucleic acids encoding antibody polypeptides that antagonize CD40L

Antibody polypeptides that antagonize CD40L

Compositions monovalent for CD28 binding and methods of use

Compositions monovalent for CD28 binding and methods of use

Polynucleotides and polypeptides associated with the development of...

Compositions and methods involving glucocorticoid receptor site II

Polynucleotides and polypeptides associated with the development of...

Methods of treating inflammatory and immune diseases using inhibito...

Intracellular targeted delivery of compounds by 70 kD heat shock pr...

Compositions comprising a peptide inhibitor of nuclear protein tran...

Peptide inhibitors of nuclear protein translocation having nuclear...

Patents Applicationslast 30 patents

METHODS OF DIAGNOSING AND TREATING LUPUS

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...

METHODS OF TREATING TRANSPLANT REJECTION USING A DOMAIN ANTIBODY DI...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

METHODS OF DIAGNOSING AND TREATING LUPUS

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANT...

METHODS OF TREATING TRANSPLANT REJECTION USING A DOMAIN ANTIBODY DI...

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

ANTIBODY POLYPEPTIDES THAT ANTAGONIZE CD40L

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE DEVELOPMENT OF...

COMPOSITIONS MONOVALENT FOR CD28 BINDING AND METHODS OF USE

Polynucleotides and polypeptides associated with the development of...

Compositions and methods involving nuclear hormone receptor site II

Polynucleotides and polypeptides associated with the NF-kappaB pathway

Polynucleotides and polypeptides associated with the NF-kB pathway

Polynucleotides and polypeptides associated with the NF-kB pathway

Polynucleotide encoding an activated human T-lymphocyte-derived pro...

Polynucleotides and polypeptides associated with the development of...

Polynucleotides and polypeptides associated with the development of...

Methods of treating inflammatory and immune diseases using inhibito...